{
    "nctId": "NCT02610920",
    "briefTitle": "Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection",
    "officialTitle": "Identification of Sentinel Lymph Nodes by Ultrasound Utilizing Iron Tracer Injection and Preoperative Biopsy in Women With Breast Cancer",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Neoplasm, Carcinoma, Ductal, Breast, Carcinoma, Intraductal, Noninfiltrating",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Success rate of core needle biopsy of sentinel lymph node",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients at least 21 years old\n* Patients with invasive ductal carcinoma staged T1 or T2 with estrogen receptor and progesterone receptor positive (ER+/PR+) who are scheduled for sentinel lymph node biopsy\n* Patients with Ductal Carcinoma In Situ (DCIS) (high or low grade) who are scheduled for sentinel lymph node biopsy including:\n* Patients having a mastectomy\n* Patients with palpable DCIS\n* Patients undergoing breast conservation with large (\\>5cm) area of DCIS\n* Patients with signed consent to participate\n\nExclusion Criteria:\n\n* Preoperative palpable axillary lymphadenopathy\n* Preoperative ultrasound demonstrating suspicious adenopathy\n* Previous axillary dissection or previous lymph node biopsy\n* Patients with Invasive Lobular Carcinoma\n* Patients who are pregnant",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}